Minimal impact of ZAP on lentiviral vector production and transduction efficiency is a research paper published in Molecular Therapy — Methods & Clinical Development (2021). On theSindex it has a DataRank of 0.241. It has been cited 4 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.241
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Medical Research Council
Grant: MC/PC/15068
Medical Research Council
Grant: MR/M019756/1
Regulation of CD4 T cell and HIV-1 gene expression by Sam68
Medical Research Council
Grant: MR/N013700/1
DTP Bid Led by King's College London
Medical Research Council
Grant: MR/R50225X/1
Kings College London and DRI NPIF Studentships 2017
Medical Research Council
Grant: MR/S000844/1
Regulation of HIV-1 and Ebola virus replication by CpG dinucleotides, ZAP and TRIM25
Biotechnology and Biological Sciences Research Council
Grant: BB/P504609/1
RNA Metabolism of lentiviral vectors
National Institute of Allergy and Infectious Diseases
Grant: 1513
National Institute of Allergy and Infectious Diseases
Grant: 183-H12-5C
Deutsche Forschungsgemeinschaft
Grant: KM 5/1-1
Wellcome Trust
Grant: 106223/Z/14/Z
Wellcome Trust
Grant: WT098049AIA
Medical Research Council
Grant: MC_PC_15068
Medical Research Council
Grant: 1939180
Wellcome Trust
Grant: 207442/Z/17/Z
Wellcome Trust
Grant: 106223
Interferon and MX2 Mediated Control of HIV-1.
Wellcome Trust
Grant: 098049
The molecular and cellular basis for the function of the HIV-1 Vpu protein in the targeting of host antiviral and immuno-modulatory factors.
Deutsche Forschungsgemeinschaft
Grant: unidentified
unidentified
NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research
European Commission
National Institutes of Health
FWCI
0.14
Citation Percentile
0.4%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals